Life Sciences

For over 35 years, attorneys in our Life Sciences practice group have played an instrumental role in the growth of many of the industry's most sophisticated life sciences companies. Our client base includes both public and private companies, based in the U.S. and abroad, and spans the breadth of the life science industry sectors from therapeutics to drug delivery and formulation to medical technology and devices.

We deliver an unparalleled combination of innovative legal expertise, deep industry knowledge and practical understanding of our clients' business needs.

Because of our deep domain expertise we are often called upon to represent venture capital clients in their investments in life sciences companies, as well as the investment banks and lending institutions servicing those companies.

Key Facts

  • Since 2001, we have completed more than 260 life sciences public offerings
  • We have closed more than 150 M&A deals for life sciences companies since 2007, with a total deal value in excess of $37 billion
  • In the last four years, our dedicated life science transactions team has completed more than 115 deals valued in excess of $35 billion.

Rankings and Accolades

  • Named "Law Firm of the Year" in Biotechnology by US News – Best Lawyers in 2011, the first year the category was awarded
  • Ranked #1 in issuer-side life sciences IPOs from 2004 to present (Source: IPO Vital Signs)
  • Consistently ranked #1 in the BioPharm Insight Biotechnology and Pharmaceutical Licensing League Table Report for value and volume from 2010 - 2012 and for volume in 2013 
  • Ranked #1 in Life Sciences by Chambers USA: America's Leading Lawyers for Business from 2007-2013
  • Fifteen Cooley transactions have been awarded or nominated for the Allicense "Breakthrough Deal of the Year" since 2000
  • Rank #1 in life sciences venture financings for 2013 per VentureSource
  • Ranked as Law Firm of the Year in Life Sciences in the Financial & Transactional and M&A categories by Euromoney's LMG Life Sciences Awards in 2013

Life Science Industry Knowledge

Many of our attorneys have practical business experience, or have earned advanced degrees in relevant life science disciplines

  • 82 attorneys with undergraduate degrees in scientific or clinical fields, including Chemistry, Biology, Mechanical Engineering, Chemical Engineering, Medicine and Nursing
  • 45+ attorneys with Ph.D.s in scientific fields

Our attorneys have deep expertise across all aspects of life sciences technologies:

  • Biologics
  • Biosimilars
  • Biotechnology
  • Chemicals
  • CLIA laboratories
  • Delivery devices
  • Diagnostic
  • Dietary supplements
  • Drug delivery
  • Drug discovery tools
  • Drug formulation
  • Laboratory instrumentation
  • Medical devices
  • Medical foods
  • MEMS technology
  • Nanotechnology
  • Oncology
  • Pharmaceuticals
  • Proteomics
  • Screening assays
  • Surgical tools
  • Therapeutics
  • Vaccines

Related Practices

Expanding Cooley's National IP Practice

We now count 40 PhDs among our 45+ life sciences patent professionals. Together, we serve many of the world's most innovative companies. Intelligently. Read here.


Request a free copy of the IPO Handbook. Available in two versions—Emerging Companies and Life Sciences Companies, this introduction to IPOs  addresses the questions most often asked by companies contemplating public offerings.

©2003-2014 Cooley LLP. All rights reserved.
COOLEY® and the COOLEY LLP® logo are registered U.S. service marks of Cooley LLP.
Cooley was founded in 1920 – for our story, visit our history page.